Stock PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Real-time Estimate Cboe BZX
Other stock markets
 09:41:51 2024-04-16 am EDT 		5-day change 1st Jan Change
1.795 USD -36.68% Intraday chart for Pacific Biosciences of California, Inc. -17.83% -71.10%
Apr. 10 Goldman Sachs Cuts Price Target on Pacific Biosciences of California to $7 From $9, Maintains Buy Rating MT
Mar. 27 Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Goldman Sachs Cuts Price Target on Pacific Biosciences of California to $7 From $9, Maintains Buy Rating
MT
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
PR
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
CI
PacBio Grants Equity Incentive Award to New Employee
PR
Transcript : Pacific Biosciences of California, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 10:15 AM
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
PR
PacBio Announces PureTarget Repeat Expansion Panel, Expanding Its Portfolio of End-To-End Clinical Research Solutions
CI
PacBio to Present at Upcoming Investor Conferences
PR
Federal Circuit Affirms Claim Construction And How It Applies
AQ
UBS Trims Pacific Biosciences of California Price Target to $12 From $12.50, Maintains Buy Rating
MT
Pacific Biosciences of California Q4 Non-GAAP Loss Narrows, Revenue Rises; Shares Drop After Hours
MT
Transcript : Pacific Biosciences of California, Inc., Q4 2023 Earnings Call, Feb 15, 2024
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q4 Revenue $58.4M, vs. Street Est of $58.3M
MT
Pacific Biosciences: Q4 Earnings Snapshot
AQ
Pacific Biosciences of California, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results
PR
Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch
PR
PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
PR
Pacific Biosciences of California, Inc Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
CI
PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PACB Stock
  4. News Pacific Biosciences of California, Inc.